English
Back
Download
Log in to access Online Inquiry
Back to the Top

Positivity!

Eupraxia Pharmaceuticals Announces Data From RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
Consistent improvement in patient report
https://www.moomoo.com/t/news/post/43464643/YRmb6ey7ea
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
2592 Views
Comment
Sign in to post a comment
    Just exploring the app to grow my money. Don't scold me if I'm copying u k 😂
    498
    Followers
    42
    Following
    1803
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.